Position in ABBV
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$7,974,974
+$1,087,284 QoQ
Shares Held
31,692
+0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
3.86%
of 13F equity value
Holder Rank
#1,032
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Charles Schwab Trust Co holds $19,134,040 across 8 Drug Manufacturers - General names. ABBV ranks #1 (41.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
31,692 | $7,974,974 | |
| 2 | JNJ |
Johnson & Johnson
|
15,446 | $3,922,820 | |
| 3 | AMGN |
Amgen Inc
|
7,464 | $2,702,863 | |
| 4 | LLY |
ELI LILLY & Co
|
1,832 | $2,197,355 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,250 | $1,060,125 | |
| 6 | BIIB |
Biogen Inc.
|
3,101 | $670,002 | |
| 7 | PFE |
Pfizer Inc
|
16,129 | $388,386 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,775 | $217,515 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,974,974 | 31,692 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $6,887,690 | 31,669 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $7,543,368 | 33,014 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $7,433,591 | 32,105 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $3,081,848 | 16,603 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $3,971,451 | 18,955 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $3,838,853 | 21,603 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $4,209,286 | 21,315 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $3,673,100 | 21,415 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $3,748,528 | 20,585 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $3,889,127 | 25,096 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $3,606,059 | 24,192 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $2,609,854 | 19,371 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $3,135,604 | 19,675 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $2,928,211 | 18,119 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $2,073,812 | 15,452 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $2,327,725 | 15,198 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $2,491,306 | 15,368 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $2,000,128 | 14,772 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $1,596,152 | 14,797 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $1,650,288 | 14,651 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $1,610,205 | 14,879 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $1,571,890 | 14,670 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $1,284,945 | 14,670 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $1,417,719 | 14,440 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $590,624 | 7,752 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||